Home > Insider Trading > Filing (0001225208-13-003633)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
9892	Bard C R Inc	BCR	Surgical & Medical Instruments & Apparatus (3841)	221454160

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1204528	L Herbert Henkel	C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-02-07	1,200	$39.36	10,865	No	4	M	Direct
Common Stock	Acquisiton	2013-02-07	1,200	$35.71	12,065	No	4	M	Direct
Common Stock	Disposition	2013-02-07	2,400	$101.14	9,665	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right to Buy)	Disposition	2013-02-07	1,200	$0.00	1,200	$35.71
Common Stock	Option (Right to Buy)	Disposition	2013-02-07	1,200	$0.00	1,200	$39.36

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2013-07-09	No	4	M	Direct
0		2013-12-10	No	4	M	Direct

Footnotes

Includes 19.3783 shares acquired under the Company's Dividend Reinvestment Plan from December 12, 2012 to February 7, 2013.
Represents the weighted average sales price for price increments ranging from $101.09 to $101.16. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Award/Grant pursuant to the 2005 Directors' Stock Award Plan, as amended and restated (formerly known as the 1988 Directors' Stock Award Plan).
This option, previously reported as covering 600 shares at an exercise price of $71.42, was adjusted to reflect the 2-for-1 stock split on May 28, 2004.
Options vested in three equal annual installments beginning on July 9, 2004 and are currently exerciseable.
This option, previously reported as covering 600 shares at an exercise price of $78.725, was adjusted to reflect the 2-for-1 stock split on May 28, 2004.
Options vested in three equal annual installments beginning on December 10, 2004 and are currently exerciseable.